|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
03692 HANSOH PHARMA
Nominal 
24.450 0.000 (0.000%) Ranking Overview
Ranking based on 12 research report(s)
Average Ranking 2.08
|
Strong Buy (1)
0
|
Buy (2)
11
|
Hold (3)
1
|
Sell (4)
0
|
Strong Sell (5)
0
|
Previous Financial Performance
| Financial Year | 12/2024 | EPS | 74.00 RMB (cts) | |
| Net Profit | 4,371.83 RMB (MIL) | DPS | 31.06 RMB (cts) |
Consolidation Estimation
| Financial Year | Profit / (Loss) (RMB (MIL)) |
EPS/ ((LPS)(RMB (cts)) |
DPS (RMB (cts)) |
Net Asset Value per Share (RMB) |
Highest (RMB (MIL)) |
Lowest (RMB (MIL)) |
| 2025 | 4,297.00 | 72.45 | 20.42 | -- | 4,681.70 | 3,371.00 |
| 2026 | 4,473.82 | 75.57 | 22.27 | -- | 4,985.00 | 3,683.00 |
| 2027 | 5,134.59 | 86.50 | 29.00 | -- | 5,777.00 | 4,714.00 |
Profit Estimation
| Profit Estimation | Profit / (Loss) (RMB (MIL)) |
EPS*/ (LPS) (RMB (cts)) |
DPS * (RMB (cts)) |
Broker | Ranking | Target Price* (HKD) |
Update Date | |
| 2025 | 4,353.00 | 73.20 | 29.20 | CITIGROUP | Buy | 32.00 | 24/03/2025 | |
| 2025 | 4,274.00 | 72.00 | -- | CMB INT'L SEC | Buy | 25.24 | 24/03/2025 | |
| 2025 | 4,008.82 | 68.00 | 20.42 | MORGAN STANLEY | Overweight | 25.00 | 24/03/2025 | |
| 2025 | 4,681.70 | 79.00 | -- | DEUTSCHE | Buy | 24.70 | 21/03/2025 | |
| 2025 | 4,154.00 | 70.00 | -- | BOCOM | Buy | 24.60 | 24/03/2025 | |
| 2025 | 4,007.00 | 67.00 | 24.00 | UBS | Buy | 24.00 | 22/03/2025 | |
| 2025 | 3,874.00 | 65.30 | -- | BANK OF AMERICA | Buy | 24.00 | 17/02/2025 | |
| 2025 | 4,320.00 | 72.90 | 18.20 | BOCI | Buy | 23.90 | 24/03/2025 | |
| 2025 | 4,400.00 | 74.00 | 31.55 | HUATAI FIN HLDGS HK | Buy | 23.82 | 23/03/2025 | |
| 2025 | 4,405.00 | 74.00 | 32.00 | CICC | OutPerform | 23.30 | 22/03/2025 | |
| 2025 | 3,371.00 | 57.00 | 19.00 | HSBC | Buy | 22.00 | 15/11/2024 | |
| 2025 | 4,354.00 | 73.59 | -- | NOMURA | Neutral | 19.86 | 21/03/2025 | |
| 2026 | 4,621.00 | 77.70 | 31.00 | CITIGROUP | -- | -- | 24/03/2025 | |
| 2026 | 4,280.10 | 72.00 | -- | CMB INT'L SEC | -- | -- | 24/03/2025 | |
| 2026 | 4,502.64 | 76.00 | 22.27 | MORGAN STANLEY | -- | -- | 24/03/2025 | |
| 2026 | 4,829.00 | 81.00 | -- | DEUTSCHE | -- | -- | 21/03/2025 | |
| 2026 | 4,985.00 | 84.00 | -- | BOCOM | -- | -- | 24/03/2025 | |
| 2026 | 4,433.00 | 75.00 | 26.00 | UBS | -- | -- | 22/03/2025 | |
| 2026 | 3,683.00 | 62.10 | -- | BANK OF AMERICA | -- | -- | 17/02/2025 | |
| 2026 | 4,544.00 | 76.60 | 19.20 | BOCI | -- | -- | 24/03/2025 | |
| 2026 | 4,179.00 | 70.00 | 29.88 | HUATAI FIN HLDGS HK | -- | -- | 23/03/2025 | |
| 2026 | 4,683.00 | 79.00 | 32.00 | CICC | -- | -- | 22/03/2025 | |
| 2026 | 3,766.00 | 63.00 | 22.00 | HSBC | -- | -- | 15/11/2024 | |
| 2026 | 4,445.00 | 75.14 | -- | NOMURA | -- | -- | 21/03/2025 | |
| 2027 | 4,957.00 | 83.40 | 33.30 | CITIGROUP | -- | -- | 24/03/2025 | |
| 2027 | 5,355.60 | 90.00 | -- | CMB INT'L SEC | -- | -- | 24/03/2025 | |
| 2027 | 5,051.18 | 85.00 | 25.99 | MORGAN STANLEY | -- | -- | 24/03/2025 | |
| 2027 | 5,777.00 | 97.00 | -- | DEUTSCHE | -- | -- | 21/03/2025 | |
| 2027 | 5,747.00 | 96.80 | -- | BOCOM | -- | -- | 24/03/2025 | |
| 2027 | 4,894.00 | 82.00 | 29.00 | UBS | -- | -- | 22/03/2025 | |
| 2027 | 5,218.00 | 88.00 | 22.00 | BOCI | -- | -- | 24/03/2025 | |
| 2027 | 4,714.00 | 79.00 | 33.78 | HUATAI FIN HLDGS HK | -- | -- | 23/03/2025 | |
| Remarks: | Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa. |
| *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue | |
| Real time quote last updated: 02/04/2025 17:51 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 4,371,825 |
| %Change | 33.389% |
| EPS / (LPS) | RMB 0.740 |
| NBV Per Share (¥) | RMB 4.832 |